The estimated Net Worth of Mark C Miller is at least $70 Milion dollars as of 7 March 2023. Mr. Miller owns over 55,282 units of Accelerate Diagnostics Inc stock worth over $89,004 and over the last 21 years he sold AXDX stock worth over $69,741,642. In addition, he makes $133,904 as Independent Director at Accelerate Diagnostics Inc.
Sign up
Mr. Miller AXDX stock SEC Form 4 insiders trading
Mark has made over 38 trades of the Accelerate Diagnostics Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 55,282 units of AXDX stock worth $89,004 on 7 March 2023.
The largest trade he's ever made was exercising 260,314 units of Accelerate Diagnostics Inc stock on 8 April 2019 worth over $13,411,377. On average, Mark trades about 15,426 units every 39 days since 2003. As of 7 March 2023 he still owns at least 55,282 units of Accelerate Diagnostics Inc stock.
You can see the complete history of Mr. Miller stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mark Miller biography
Mark C. Miller serves as Independent Director of the Company. since November 5, 2013. Before retiring, Mr. Miller served as Chief Executive Officer of Stericycle (NASDAQ: SRCL) from 1992 to 2012. Prior to joining Stericycle, Mr. Miller served as Vice President for the Pacific, Asia and Africa in the international division of Abbott Laboratories, a diversified health care company, which he joined in 1976 and where he held a number of management and marketing positions. Mr. Miller formerly served as a director of Stericycle and Ventana Medical Systems, Inc., a developer and supplier of automated diagnostic systems. He received a B.S. degree in computer science from Purdue University, where he graduated Phi Beta Kappa. Mr. Miller was selected by Morningstar, Inc. as its “2009 CEO of the Year.”
What is the salary of Mark Miller?
As the Independent Director of Accelerate Diagnostics Inc, the total compensation of Mark Miller at Accelerate Diagnostics Inc is $133,904. There are 8 executives at Accelerate Diagnostics Inc getting paid more, with John Phillips having the highest compensation of $12,300,900.
How old is Mark Miller?
Mark Miller is 64, he's been the Independent Director of Accelerate Diagnostics Inc since 2013. There are 5 older and 9 younger executives at Accelerate Diagnostics Inc. The oldest executive at Accelerate Diagnostics Inc is Jack Schuler, 79, who is the Independent Director.
What's Mark Miller's mailing address?
Mark's mailing address filed with the SEC is C/O ACCELERATE DIAGNOSTICS, INC., 3950 S. COUNTRY CLUB ROAD, SUITE 470, TUCSON, AZ, 85714.
Insiders trading at Accelerate Diagnostics Inc
Over the last 12 years, insiders at Accelerate Diagnostics Inc have traded over $26,833,308 worth of Accelerate Diagnostics Inc stock and bought 16,366,880 units worth $209,384,489 . The most active insiders traders include Jack W Schuler, Larry N Feinberg oraz Matthew Strobeck. On average, Accelerate Diagnostics Inc executives and independent directors trade stock every 16 days with the average trade being worth of $132,645. The most recent stock trade was executed by Hany Massarany on 28 June 2024, trading 4,737 units of AXDX stock currently worth $7,627.
What does Accelerate Diagnostics Inc do?
accelerate diagnostics, inc. (nasdaq:axdx), is an in vitro diagnostics company focused on developing and commercializing innovative systems for the rapid identification and antimicrobial susceptibility testing of infectious pathogens. the company's revolutionary id/ast platform utilizes a proprietary process with both genomic and phenotypic detection technologies that significantly decreases time to result while achieving high sensitivity and specificity. in addition to the id/ast development pipeline, the company also owns and licenses its proprietary optichem™ surface coatings technology, which has numerous applications for binding in bio-analytical systems, such as microarrays.
What does Accelerate Diagnostics Inc's logo look like?
Complete history of Mr. Miller stock trades at Accelerate Diagnostics Inc i Stericycle
Accelerate Diagnostics Inc executives and stock owners
Accelerate Diagnostics Inc executives and other stock owners filed with the SEC include:
-
John Phillips,
Chief Executive Officer, Chief Operating Officer, Director -
Steve Reichling,
Chief Financial Officer -
Jack Phillips,
CEO, Pres & Director -
Ron Price,
Senior Vice President, Head of Commercial Operations, Americas -
Roland Diggelmann,
Independent Director -
Louise Francesconi,
Independent Director -
Steve Reichling,
CFO & Chief Accounting Officer -
Ron Price,
Chief Commercial Officer of Americas -
Charles Watts,
Independent Director -
Frank ten Brink,
Independent Director -
Matthew Strobeck,
Independent Director -
Jack Schuler,
Independent Director -
Mark Miller,
Independent Director -
Thomas Brown,
Independent Director -
John Patience,
Independent Chairman of the Board -
Nedal Safwat,
Chief Strategy Officer -
Dr. Lawrence Mertz,
Sr. VP and Head of R&D -
John Meduri,
Chief Strategy Officer -
Laura Costa,
Sr. VP & Head of Global Customer Support -
Cherif Bousselham,
Sr. VP & Head of Sales - EMEA -
Gretchen Strohminger,
Sr. VP and Head of HR & Culture -
Michael Bridge,
Sr. VP, Gen. Counsel & Sec. -
Laura Pierson,
Investor Relations Officer -
Larry N Feinberg,
10% owner -
Pete Bantock,
CHIEF COMMERCIAL OFFICER -
Lawrence Mehren,
PRESIDENT AND CEO -
Marran H. Ogilvie,
Director -
Jennifer Regan,
Director -
Mark S. Black,
Director -
Ventures, Llc Abeja,
10% owner -
Romney Humphries,
Chief Scientific Officer -
Larry Michael Mertz,
Chief Technology Officer -
Hany Massarany,
Director -
Jack Phillips,
Chief Executive Officer -
Wayne Burris,
Director -
David Patience,
Chief Financial Officer